Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Arthritis Rheum. 2012 Sep;64(9):2937–2946. doi: 10.1002/art.34502

Fig. 5.

Fig. 5

Simulation of FoxP3 expression by NAC in lupus T cells. A) FoxP3 expression in CD4+/CD25+ and CD8+/CD25+ T cell subsets of lupus and control donors matched for age, gender, and ethnicity by flow cytometry. Red and blue values indicate percentage of FoxP3+ cells in lupus and control donors, respectively. B) Cumulative analysis of FoxP3 expression in CD25+ T-cell subsets in lupus subjects and matched controls. p values reflect comparison with two-tailed unpaired t-test. C) Effect of NAC on Foxp3 expression in CD25+ T cell subsets of lupus patients exposed to all doses considered together. p values reflect comparison with two-tailed paired t-test.

HHS Vulnerability Disclosure